ProtagonistandTakedaPresentLonger-TermDataatASH2025ShowingRusfertideDeliversDurableResponseandHematocritControlinPolycythemiaVera
===2025/12/8 11:31:44===
ess release contains forward-looking statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements regarding the potential benefits of rusfertide and the timing of rusfertide regulatory submissions. In some cases, you can identify these statements by forward-looking words such as "anticipate," "believe," "may," "will," "expect," or the negative or plural of these words or similar expressions. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties that could cause actual results and events to differ materially from those anticipated, including, but not limited to, our ability to develop and commercialize our product candidates, our ability to earn milestone payments under our collaboration agreements with Janssen and Takeda, our ability to use and expand our programs to build a pipeline of
=*=*=*=*=*=
当前为第14/23页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页